BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25533357)

  • 1. Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.
    Kimishima K; Matsuno T; Makiishi J; Tamazawa G; Sogo Y; Ito A; Satoh T
    Odontology; 2016 Jan; 104(1):105-13. PubMed ID: 25533357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gatifloxacine-loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis.
    Tamazawa G; Ito A; Miyai T; Matsuno T; Kitahara K; Sogo Y; Kimishima K; Satoh T
    Dent Mater J; 2011; 30(3):264-73. PubMed ID: 21597226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-loaded poly-epsilon-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis.
    Miyai T; Ito A; Tamazawa G; Matsuno T; Sogo Y; Nakamura C; Yamazaki A; Satoh T
    Biomaterials; 2008 Jan; 29(3):350-8. PubMed ID: 17977596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro/in vivo evaluation of the efficacy of gatifloxacine-loaded PLGA and hydroxyapatite composite for treating osteomyelitis.
    Makiishi J; Matsuno T; Ito A; Sogo Y; Satoh T
    Dent Mater J; 2017 Nov; 36(6):714-723. PubMed ID: 28626206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the biomaterials 3wt%-nanostrontium-hydroxyapatite-enhanced calcium phosphate cement (nanoSr-CPC) and nanoSr-CPC-incorporated simvastatin-loaded poly(lactic-co-glycolic-acid) microspheres in osteogenesis improvement: An explorative multi-phase experimental in vitro/vivo study.
    Masaeli R; Jafarzadeh Kashi TS; Dinarvand R; Rakhshan V; Shahoon H; Hooshmand B; Mashhadi Abbas F; Raz M; Rajabnejad A; Eslami H; Khoshroo K; Tahriri M; Tayebi L
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():171-83. PubMed ID: 27612702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro degradation, biocompatibility, and in vivo osteogenesis of poly(lactic-co-glycolic acid)/calcium phosphate cement scaffold with unidirectional lamellar pore structure.
    He F; Ye J
    J Biomed Mater Res A; 2012 Dec; 100(12):3239-50. PubMed ID: 22733543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis.
    Ahola N; Veiranto M; Männistö N; Karp M; Rich J; Efimov A; Seppälä J; Kellomäki M
    Biomatter; 2012; 2(4):213-25. PubMed ID: 23507887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.
    Ahola N; Männistö N; Veiranto M; Karp M; Rich J; Efimov A; Seppälä J; Kellomäki M
    Biomatter; 2013; 3(2):. PubMed ID: 23507926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen I gel can facilitate homogenous bone formation of adipose-derived stem cells in PLGA-beta-TCP scaffold.
    Hao W; Hu YY; Wei YY; Pang L; Lv R; Bai JP; Xiong Z; Jiang M
    Cells Tissues Organs; 2008; 187(2):89-102. PubMed ID: 17938566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.
    Chen SH; Wang XL; Xie XH; Zheng LZ; Yao D; Wang DP; Leng Y; Zhang G; Qin L
    Acta Biomater; 2012 Aug; 8(8):3128-37. PubMed ID: 22543006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro elution of vancomycin from biodegradable osteoconductive calcium phosphate-polycaprolactone composite beads for treatment of osteomyelitis.
    Makarov C; Cohen V; Raz-Pasteur A; Gotman I
    Eur J Pharm Sci; 2014 Oct; 62():49-56. PubMed ID: 24859314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
    Ruhé PQ; Boerman OC; Russel FG; Spauwen PH; Mikos AG; Jansen JA
    J Control Release; 2005 Aug; 106(1-2):162-71. PubMed ID: 15972241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoconductive properties of poly(96L/4D-lactide)/beta-tricalcium phosphate in long term animal model.
    Daculsi G; Goyenvalle E; Cognet R; Aguado E; Suokas EO
    Biomaterials; 2011 Apr; 32(12):3166-77. PubMed ID: 21315446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo analysis of a biodegradable poly(lactide-co-glycolide) copolymer capsule and collagen composite system for antibiotics and bone cells delivery.
    Ueng SW; Yuan LJ; Lin SS; Liu SJ; Chan EC; Chen KT; Lee MS
    J Trauma; 2011 Jun; 70(6):1503-9. PubMed ID: 21336203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenic activity of cyclodextrin-encapsulated doxycycline in a calcium phosphate PCL and PLGA composite.
    Trajano VCC; Costa KJR; Lanza CRM; Sinisterra RD; Cortés ME
    Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():370-375. PubMed ID: 27127066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolytic degradation of composites of poly(L-lactide-co-epsilon-caprolactone) 70/30 and β-tricalcium phosphate.
    Ahola N; Veiranto M; Rich J; Efimov A; Hannula M; Seppälä J; Kellomäki M
    J Biomater Appl; 2013 Nov; 28(4):529-43. PubMed ID: 23048066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone augmentation using a highly porous PLGA/β-TCP scaffold containing fibroblast growth factor-2.
    Yoshida T; Miyaji H; Otani K; Inoue K; Nakane K; Nishimura H; Ibara A; Shimada A; Ogawa K; Nishida E; Sugaya T; Sun L; Fugetsu B; Kawanami M
    J Periodontal Res; 2015 Apr; 50(2):265-73. PubMed ID: 24966062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistically enhanced osteoconductivity and anti-inflammation of PLGA/β-TCP/Mg(OH)
    Lee SK; Han CM; Park W; Kim IH; Joung YK; Han DK
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():65-75. PubMed ID: 30423751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Injectable borate glass/chitosan composite as drug carrier for treatment of chronic osteomyelitis].
    Zhao C; Wang X; Zhang C; Cui X; Jia W; Huang W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Jun; 26(6):641-6. PubMed ID: 22792754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-Healing Capacity of PCL/PLGA/Duck Beak Scaffold in Critical Bone Defects in a Rabbit Model.
    Lee JY; Son SJ; Son JS; Kang SS; Choi SH
    Biomed Res Int; 2016; 2016():2136215. PubMed ID: 27042660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.